Instil Bio Gross Profit

Instil Bio (TIL) currently reports a gross profit of $-12K as of June 2026. That compares with $-12K in the prior-year period — up 0.0% year over year. That is below the Healthcare sector average of $67B. Use the charts on this page to explore Instil Bio's gross profit history and peer comparisons.

Instil Bio's gross profit was unchanged from $-12K to $-12K — essentially flat versus a year earlier (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Instil Bio's gross profit of $-12K is lower than the Healthcare sector average of $67B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Instil Bio reported $-12K in gross profit as of June 2026. That compares with $-12K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current gross profit of $-12K, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $67B. From there, open related valuation or income-statement pages for Instil Bio, and consider following TIL for alerts when major investors trade the stock.